Prediction of depressive relapse in remitted bipolar patients using corticotrophin-releasing hormone challenge test

Acta Psychiatrica Scandinavica

Volumn 95, Issue 3, 1997, Pages 205-211

  Vieta, E ^a,b   Gasto, C ^a   Martinez De Osaba, M J ^a   Nieto, E ^a   Canto, T J ^a   Otero, A ^a   Vallejo, J ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

ACTH; Bipolar disorder; Corticotrophin releasing hormone; Cortisol

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; LITHIUM;

ADULT; ARTICLE; BIPOLAR DEPRESSION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MALE; PREDICTION; PRIORITY JOURNAL; PROVOCATION TEST; RELAPSE;

EID: 0030889592     PISSN: 0001690X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0447.1997.tb09621.x     Document Type: Article

References (32)

1. OWENS MJ, NEMEROFF CHB. The role of corticotropin-releasing factor in the pathophysiology of affective and anxiety disorders: laboratory and clinical studies. In: NEMEROFF CHB, LOOSEN PT, ed. Corticotropin-releasing factor (Ciba Foundation Symposium 172). Chichester: Wiley, 1993: 296-308.
2. GOLD PW, CHROUSOS G, KEELNER C et al. Psychiatric implications of basic and clinical studies with corticotropin-releasing factor. Am J Psychiatry 1984: 141: 619-627.
3. GOLD P, LORIAUX DL, ROY A et al. Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implications. N Engl J Med 1986: 314: 1329-1334.
4. HOLSBOER F, VON BARDELEBEN U, GERKEN A et al. Blunted corticotropin and normal cortisol response to human corticotropin-releasing factor in depression. N Engl J Med 1984: 311: 1127-1137.
5. HOLSBOER F, GERKEN A, VON BARDELEBEN U et al. Human corticotropin-releasing hormone in depression. Correlation with thyrotropin secretion following thyrotropin-releasing hormone. Biol Psychiatry 1986: 21: 601-611.
6. AMSTERDAM JD, MAISLIN G, WINOKUR A et al. The CRH stimulation test before and after clinical recovery from depression. J Affect Dis 1988: 14: 213-222.
7. VIETA E, MARTINEZ DE OSABA MJ, NIETO E et al. Papel del factor liberador de corticotropina en la regulación de mecanismos psicofisiológicos y en la fisiopatología de los trastornos afectivos (Role of corticotropin-releasing factor in the regulation of psychophysiological mechanisms and the pathophysiology of affective disorders). Focus Psychiatry 1993: 3: 59-64.
8. BANKI CM, KARMACSI L, BISSETTE G et al. CSF corticotropin-releasing hormone and somatostatin in major depression: response to antidepressant treatment and relapse. Eur Neuropsychopharmacology 1992: 2: 107-113.
9. SPITZER RL, ENDICOTT J, ROBINS E. Research Diagnostic Criteria: rationale and reliability. Arch Gen Psychiatry 1978: 35: 773-782.
10. ENDICOTT J, SPITZER R. A diagnostic interview: the Schedule for Affective Disorders and Schizophrenia. Arch Gen Psychiatry 1978: 35: 837-844.
11. YOUNG RC, BIGGS JT, ZIEGLER VE et al. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978: 133: 429-435.
12. HAMILTON M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960: 23: 56-62.
13. HOLMES T, RAHE R. The social adjustment rating scale. J Psychosom Res 1967: 4: 213-218.
14. GONZALEZ DE RIVERA JL, MORERA A. La valoración de sucesos vitales: adaptación española de la escala de Holmes y Rahe (Life events assessment: the Spanish version of the Holmes-Rahe rating scale). Psiquis 1983: 4: 20-25.
15. DUNNER DL, FIEVE RR. Clinical factors in lithium carbonate prophylaxis failure. Arch Gen Psychiatry 1974: 30: 229-233.
16. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, revised 3rd edn. Washington, DC: American Psychiatric Association, 1987.
17. FAICT D, DE MOOR P. Use of monoclonal antibodies in an RIA for human transcortin. Clin Chem 1984: 30: 369-372.
18. BANKI CM, BISSETTE G, ARATO M et al. CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia. Am J Psychiatry 1987: 144: 873-877.
19. POLAND RE, HANADA K. Dissociation between plasma bioactive and immunoactive ACTH concentrations in depressed patients. Biol Psychiatry 1994: 35: 309-315.
20. REUS V, JOSEPH M, DALLMAN M. Regulation of ACTH and cortisol in depression. Peptides 1983: 4: 785-788.
21. MELTZER HY, LOWY M, ROBERTSON A et al. Effect of 5-hydroxy-tryptophan on serum cortisol levels in major affective disorders. III. Effect of antidepressants and lithium carbonate. Arch Gen Psychiatry 1984: 41: 391-397.
22. THALÉN BE, KJELLMAN BF, LJUNGGREN JG et al. Release of corticotropin after administration of corticotropin-releasing hormone in depressed patients in relation to the dexamethasone suppression test. Acta Psychiatr Scand 1993: 87: 133-140.
23. BERRETTINI WH, NURNBERGER JI, ZERBE RL et al. CSF neuropeptides in euthymic bipolar patients and controls. Br J Psychiatry 1987: 150: 208-212.
24. GOLD P, KLING MA, CALABRESE JR et al. Physiological, diagnostic, and pathophysiological implications of corticotropin-releasing hormone. In: NEMEROFF CHB, LOOSEN PT, ed. Handbook of clinical psychoneuroendocrinology. Chichester: Wiley, 1987: 85-105.
25. TSUKADA T, NAKAI Y, KOH T et al. Plasma adrenocorticotropin and cortisol responses to intravenous injection of corticotropin-releasing factor in the morning and evening. J Clin Endocrinol Metab 1983: 57: 869-871.
26. GOODWIN FK, JAMISON KR. Manic-depressive illness. New York: Oxford University Press, 1990.
27. WINOKUR G, CORYELL W, KELLER M et al. A prospective follow-up of patients with bipolar and primary unipolar affective disorder. Arch Gen Psychiatry 1993: 50: 457-465.
28. ROY-BYRNE P, POST RM, UHDE TW et al. The longitudinal course of recurrent affective illness. Acta Psychiatr Scand 1985: 71 (Suppl. 317): 5-34.
29. RIBEIRO SCM, TANDON R, GRUNHAUS L et al. The DST as a predictor of outcome in depression: a meta-analysis. Am J Psychiatry 1993: 150: 1618-1629.
30. HOLSBOER F. Neuroendocrinology of mood disorders. In: BLOOM FE, KUPFER DJ, ed. Psychopharmacology. The fourth generation of progress. New York: Raven Press, 1995: 957-969.
31. NEMEROFF CHB, EVANS DL. Correlation between the dexamethasone suppression test in depressed patients and clinical response. Am J Psychiatry 1984: 141: 247-249.
32. GREDEN JF, DE VIGNE JP, ALBALA AA et al. Serial dexamethasone suppression tests among rapidly cycling bipolar patients. Biol Psychiatry 1982: 17: 455-462.